zubsolv buprenorphine hydrochloride and naloxone hydrochloride tablet orally disintegrating
1 INDICATIONS AND USAGE ZUBSOLV is indicated for treatment of opioid dependence. ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support. ZUBSOLV contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for treatment of opioid dependence. ( 1 ) ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
orexo us, inc.
TRIANGLE WHITE 1 4
Related Pills
orbax orbifloxacin tablet coated
merck sharp & dohme corp.
Ondansetron Ondansetron 4 MG Oral Tablet
Glenmark Generics Inc., USA
Metformin 1000 mg
Aurobindo Pharma Limited
Metformin 1000 mg
aurobindo pharma limited
Metformin 1000 mg
aurobindo pharma limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED / STORAGE AND HANDLING ZUBSOLV sublingual tablets are menthol-flavored white tablets supplied in aluminum/aluminum child resistant unit dose blister packages. ZUBSOLV is available in six dosage strengths imprinted in their respective buprenorphine strength Buprenorphine 0.7 mg /naloxone 0.18 mg, oval shape, imprinted with “.7” Buprenorphine 1.4 mg /naloxone 0.36 mg, triangular shape, imprinted with “1.4” Buprenorphine 2.9 mg /naloxone 0.71mg, D shape, imprinted with “2.9” Buprenorphine 5.7 mg /naloxone 1.4 mg, round shape, imprinted with “5.7” Buprenorphine 8.6 mg /naloxone 2.1 mg, diamond shape, imprinted with “8.6” Buprenorphine 11.4 mg /naloxone 2.9 mg, capsule shape, imprinted with “11.4” NDC 54123-907-30 (buprenorphine 0.7 mg /naloxone 0.18 mg) sublingual tablet – 3x10 tablets per carton NDC 54123-914-30 (buprenorphine 1.4 mg /naloxone 0.36 mg) sublingual tablet – 3x10 tablets per carton NDC 54123-929-30 (buprenorphine 2.9 mg /naloxone 0.71 mg) sublingual tablet – 3x10 tablets per carton NDC 54123-957-30 (buprenorphine 5.7 mg /naloxone 1.4 mg) sublingual tablet – 3x10 tablets per carton NDC 54123-986-30 (buprenorphine 8.6 mg /naloxone 2.1 mg) sublingual tablet – 3x10 tablets per carton NDC 54123-114-30 (buprenorphine 11.4 mg /naloxone 2.9 mg) sublingual tablet – 3x10 tablets per carton Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature] Store ZUBSOLV securely and dispose of properly [see Patient Counseling Information ( 17 )].
More pills like TRIANGLE 1 4